DAEWOONG PHARMACEUTICAL HITS UPON ORAL FORMULATION –FOISTAR AGAINST COVID-19

• Daewoong Pharmaceutical announced on Nov. 23 that it has finished with assimilating patients for a second-phase clinical test of Foistar Tablet being developed as a COVID-19 treatment.
• The clinical trial will be spearheaded by Oh Myung-don, an infectious medicine professor at S...

BLOOD CANCER AND PANCREATIC DISEASE DRUGS TO BE TESTED – COVID-19

Highlights –

• UK plans to introduce two new clinical trials on COVID-19 patients.
• Patients will be given blood cancer and pancreatic disease drugs.
• Drug – Ruxolitinib, used to treat various blood cancer patients.
• Drug ...